» Articles » PMID: 38540776

Exploring SVA Insertion Polymorphisms in Shaping Differential Gene Expressions in the Central Nervous System

Overview
Journal Biomolecules
Publisher MDPI
Date 2024 Mar 28
PMID 38540776
Authors
Affiliations
Soon will be listed here.
Abstract

Transposable elements (TEs) are repetitive elements which make up around 45% of the human genome. A class of TEs, known as SINE-VNTR-Alu (SVA), demonstrate the capacity to mobilise throughout the genome, resulting in SVA polymorphisms for their presence or absence within the population. Although studies have previously highlighted the involvement of TEs within neurodegenerative diseases, such as Parkinson's disease and amyotrophic lateral sclerosis (ALS), the exact mechanism has yet to be identified. In this study, we used whole-genome sequencing and RNA sequencing data of ALS patients and healthy controls from the New York Genome Centre ALS Consortium to elucidate the influence of reference SVA elements on gene expressions genome-wide within central nervous system (CNS) tissues. To investigate this, we applied a matrix expression quantitative trait loci analysis and demonstrate that reference SVA insertion polymorphisms can significantly modulate the expression of numerous genes, preferentially in the position and in a tissue-specific manner. We also highlight that SVAs significantly regulate mitochondrial genes as well as genes within the and loci, previously associated within neurodegenerative diseases. In conclusion, this study continues to bring to light the effects of polymorphic SVAs on gene regulation and further highlights the importance of TEs within disease pathology.

Citing Articles

Alu insertion-mediated dsRNA structure formation with pre-existing Alu elements as a disease-causing mechanism.

Masson E, Maestri S, Bordeau V, Cooper D, Ferec C, Chen J Am J Hum Genet. 2024; 111(10):2176-2189.

PMID: 39265574 PMC: 11480803. DOI: 10.1016/j.ajhg.2024.08.016.


Insights into Calpain Activation and Rho-ROCK Signaling in Parkinson's Disease and Aging.

Gathings A, Zaman V, Banik N, Haque A Biomedicines. 2024; 12(5).

PMID: 38791036 PMC: 11117523. DOI: 10.3390/biomedicines12051074.

References
1.
Savage A, Schumann G, Breen G, Bubb V, Al-Chalabi A, Quinn J . Retrotransposons in the development and progression of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2018; 90(3):284-293. PMC: 6518469. DOI: 10.1136/jnnp-2018-319210. View

2.
Makino S, Kaji R, Ando S, Tomizawa M, Yasuno K, Goto S . Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am J Hum Genet. 2007; 80(3):393-406. PMC: 1821114. DOI: 10.1086/512129. View

3.
Grad L, Rouleau G, Ravits J, Cashman N . Clinical Spectrum of Amyotrophic Lateral Sclerosis (ALS). Cold Spring Harb Perspect Med. 2016; 7(8). PMC: 5538408. DOI: 10.1101/cshperspect.a024117. View

4.
Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Fernandez Altamirano P . A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int. 2015; 6:171. PMC: 4653353. DOI: 10.4103/2152-7806.169561. View

5.
Savage A, Bubb V, Breen G, Quinn J . Characterisation of the potential function of SVA retrotransposons to modulate gene expression patterns. BMC Evol Biol. 2013; 13:101. PMC: 3667099. DOI: 10.1186/1471-2148-13-101. View